RFA-DA-26-024: Engaging Loved ones in Recovery Processes to Enhance Recovery Capital and Outcomes (R61/R33 Clinical Trial Optional)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2024.
National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on February 27, 2025.
From the official notice on Grants.gov, last changed November 6, 2024. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeR61 / R33
- Clinical trialsOptional
- Funded byNIDA
- Median yearly award$453,654
- Typical project length2 years
- R61, Exploratory/Developmental Phase I. The first phase of a phased award. Moving on to the R33 phase depends on meeting agreed milestones. Other open R61 notices.
- R33, Exploratory/Developmental Grant Phase II. The second phase of a phased award, usually following an R61 or R21 phase. Other open R33 notices.
Projects funded under RFA-DA-26-024 were run by National Institute on Drug Abuse (NIDA, 7 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-DA-26-024 in the NIH Guide.
Key dates
| Posted | November 6, 2024 |
|---|---|
| Deadline | February 27, 2025 |
| Archived by Grants.gov | April 4, 2025 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Is this a realistic fit?
- Most of the program's money (70% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
Outside of research with adolescents, there is a relative dearth of research on how to effectively leverage and support relationships between people with addiction and their loved ones to improve treatment navigation, engagement and recovery outcomes. As a result, this NOFOs purpose is to address this crucial research gap by supporting studies to improve engagement of support persons. This initiative would support pragmatic trials focused on scalable, sustainable adaptations to existing EBPs and service delivery frameworks that emphasize enhancing engagement of loved ones and support persons, thereby strengthening recovery capital and increasing the likelihood of stable recovery. Approaches of interest include testing adaptations or new interventions that: 1) reduce stigma toward addiction and MOUD among support persons; 2) provide assistance to support persons in navigating care options for their loved one; 3) formally engage support persons in services; 4) leverage support persons as lay interventionists; and 5) enhance well-being and coping skills among support persons.
Funded under RFA-DA-26-024 so far
NIH funded 7 projects under RFA-DA-26-024 in fiscal 2026, at 7 institutions. The median yearly award was $453,654.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Engaging family members during early SUD treatment: A hybrid trial | Stanford University | 2026 | $744,728 |
| Development and Pilot Testing of a Novel Treatment Intervention for Dual Substance Use Disorder (DUD) in Heterosexual Couples | University of Rochester | 2026 | $433,029 |
| Harnessing mHealth to Support Loved Ones of Individuals in Recovery from Substance Use Disorders | Rhode Island Hospital | 2026 | $480,749 |
| Empowering Support Persons to Enhance the Recovery Capital of Postpartum Women with Opioid Use Disorder | Friends Research Institute, Inc. | 2026 | $448,565 |
| Optimizing a Digital Support Service for Concerned Significant Others of Individuals with SUD with Helpline, AI-Enhanced and Peer-Led Support | Partnership to End Addiction | 2026 | $453,750 |
| Support Towards Addiction Recovery for Individuals with Criminal Legal System Involvement: The STAR Project | University of Kentucky | 2026 | $422,921 |
| Recovery Inspired Support Engagement (RISE) | McLean Hospital | 2026 | $453,654 |
Who has won Drug Use and Addiction Research Programs grants before
From fiscal 2021 to 2025, Drug Use and Addiction Research Programs (93.279) awarded $7.3 billion across 5,071 grant awards, an average of $1.4 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Yale Univ | Connecticut | 150 | $305 million |
| The Johns Hopkins University | Maryland | 156 | $262 million |
| University of California, San Diego | California | 120 | $242 million |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Pennsylvania | 100 | $182 million |
| New York University | New York | 62 | $173 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-DA-26-024 still open?
No. It closed on February 27, 2025.
Who can apply for Engaging Loved ones in Recovery Processes to Enhance Recovery Capital and Outcomes (R61/R33 Clinical Trial Optional)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Engaging Loved ones in Recovery Processes to Enhance Recovery Capital and Outcomes (R61/R33 Clinical Trial Optional)?
Closed February 27, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under RFA-DA-26-024?
NIH RePORTER lists 7 projects funded under RFA-DA-26-024 in fiscal 2026, at 7 institutions. The most were at Stanford University, University of Rochester, Rhode Island Hospital.
Who has won Drug Use and Addiction Research Programs grants before?
The largest recipients over five fiscal years were Yale Univ, The Johns Hopkins University, University of California, San Diego. The program made 5,071 awards worth $7.3 billion in that time.
Similar open grants
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
- NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)